Introduction
Larynx squamous cell carcinoma (LSCC) is the second most frequent type of head and neck neoplasia. 1 Despite the advances in cancer treatment, the survival from laryngeal cancer has not been changed in the last 30 years and has one of the lowest survival rate among the main types of cancer [2] [3] .
Although former studies have approached LSCC molecular characterization 4-6 , our comprehension of the target genes involved in LSCC biology is still limited. Therefore, new efforts are needed to improve the characterization of the molecular mechanisms involved in LSCC. This is especially important, once new therapies that interfere in specific targets inside the genetic paths 2/13
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Hox genes and laryngeal carcinogenesis can become available, as demonstrated in other types of cancer [7] [8] [9] [10] . In the present study, we performed a molecular analysis in a series of 32 LSCC human samples, with the objective of identifying genes involved with LSCC pathogenesis. We applied the approach of genic expression profile together with a wide statistical analysis 11 to show that the LSCC is marked by a series of transcriptional alterations, including the super expression of eight members of the HOX genes family.
Methods
Ethics code and tissue sample collection. This study was approved by the Ethics Committee in Research of the Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP) (Proc. no. 9371/2003). Informed Consent Form was obtained from the patients submitted to surgical treatment at the Head and Neck Surgery Service of the Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery of the Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), from January 2005 to December 2009. The inclusion criteria were LSCC histopathologic diagnosis and LSCC elective surgeries without previous treatment. The exclusion criteria were LSCC dubious diagnosis and patients with incomplete clinical data. A total of 32 patients were included in this study. After LSCC histopathologic confirmation, the tumors and the surgical margins were microdissected and the tissues samples were frozen in liquid nitrogen.
Microarrays experiments. RNA was purified with the kit RNeasy (Qiagen, Valencia, CA, USA) and quantified with the spectrophotometry NanoDrop (260 nm; Thermo Fisher Scientific, Waltham, MA, USA). Agarose gel electrophoresis was used to evaluate RNAs' quality (detection of RNA ribosomal 28S and 18S). The Fluidics Station 450 (Affymetrix) system and the Kit One-Colour Quick Amp Labeling (5190-0442; Agilent, USA) were used for the chips hybridization Whole Human Genome Oligo Microarray (G4112F, Agilent Technologies, Santa Clara, CA, USA).
Each matrix reflected the expression of a single sample and the LSCC files of the scanned microarrays were produced using the scanner GenePix 4000B (Axon Instruments, USA) together with GenePix Pro 6.0 and the resources extraction of Agilent 9.5.3.1 software. Data from gross microarrays were deposited in the Gene Expression Omnibus (GEO) (access ID: GSE59102) and published in Genomic Data 11 .
Analysis of microarrays data. The data analysis was performed with R packages of the Bioconductor Project (www.bioconductor.org). Spearman correlation coefficient and Average Distance were applied for hierarchical grouping and exclusion of masked points from the set of microarrays data. The statistical significance was determined with one impaired t-test analysis. The false discovery rate (FDR) was used to adjust the p values (q values). A heat map was generated to illustrate the results.
TCGA data analysis. Differential analysis of the genic expression between LSCC and the normal tissue samples from the same patient was performed using the Bioconductor R package TCGA Biolinks 12 . P values were adjusted to 3/13
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Hox genes and laryngeal carcinogenesis FDR<0.05. Genes with log twice lower than −2 or higher than 2 and adjusted p <0.01 were considered differentially expressed.
RT-qPCR analysis. We used the high capacity reversal transcript kit cDNA (Applied Biosystems, USA) to generate cDNAs from 1 μg of RNA extracted, according to the manufacturer's instructions. After that, the cDNAs were diluted at 1:5 and stored at −80 °C until the analysis. RT-qPCR was performed with Prime Time® Mini kit qPCR Probe (Integrated DNA Technologies, USA).
For all the reactions of RT-qPCR, the average geometric expression of the genes housekeeping GAPDH and TBP were used to normalize the RNA entries. The levels of expressed genes were measured by RT-qPCR using the method 2 -ΔΔCt13 . siRNA testing. The gene silencers siRNAs HOXC8 (siHOXC8), HOXD10 (siHOXD10) and HOXD11(siHOXD11) and siRNA of negative control (siCTRL) were acquired from Sigma-Aldrich (St. Louis, MO, USA). The cells were transfected with siRNA specific (30 nM) using the reagent Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Subsequent experiences were performed 48 hours after the transfection.
Cellular feasibility. The cellular feasibility and apoptosis were evaluated using the apoptosis detection kit Anexina VFITC (Becton Dickinson, Holdrege, NE, USA). All the experiences were performed according to the manufacturer's instructions. The flow cytometer FACSCalibur was used for all the analyses (Becton Dickinson, Franklin Lakes, NJ, USA). Doubly negative cells were considered feasible. Positive cells for V Annexin were determined as apoptotic cells. The results were presented as the percentage of stained positive cells.
For the colony formation testing, the cell suspension was fixed in plates of six wells (500 cells). After 12 days, the cells were fixed in formaldehyde at 45% (in PBS) and stained with Crystal violet at 0.5%. The number of colonies was counted with the software ImageJ.
Transwell plates migration testing. Cell motility was evaluated in plates of 24 transwell wells (Greiner, USA). FADU and UMSCC14 cells (1 × 105 cells / 300 µL of serum-free means) were sown at the upper chambers of transwell plates 48 hours after transfection with individual siRNAs. The lower chambers were filled up with 500 μL of means added to FBS 10%. The cells remained at 37 ºC for 24 hours. Then, the cells of the upper compartment were removed with a swab, and the cells that migrated for the lower part of the filter were fixed in formaldehyde at 4% (in PBS) and stained with crystal violet at 0.5%. The number of cells was manually counted using the software ImageJ.
Statistical analysis. Data were analyzed using the software package GraphPad Prism 5.0 (Graph Pad Software Inc., USA). The statistical significance was determined by one-way ANOVA followed by the Bonferroni post hoc test. The Mann-Whitney test was applied for comparison between two independent groups. IBM SPSS Statistics for Mac (release 20.0) was used for survival analysis (Kaplan-Meier test), curve analysis (ROC) and classification of categorical data (Fisher test). A probability of p<0.05 was considered to be statistically significant. All data are shown as average ± standard deviation.
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Hox genes and laryngeal carcinogenesis LSCC microarrays analysis. The microarrays analysis was performed from surgical samples incorporating the tumor, as well as non-neoplastic tissues. The statistical analysis revealed transcriptomic differences between the non-Vtumor and tumor samples, from which 30 (42%) among 70 differentially expressed genes were significantly super expressed in LSCC (Table 1 ). Figure 1b shows the heat map with hierarchical grouping using the expression standard of this group of 70 differentially expressed genes. Eight members of the HOX gene family were super expressed in the LSCC. On average, the members of the HOX gene family showed super expression of 4.2 (± 0.7) times in the tumors compared to the tissue from margins.
Results
Clinical characteristics of the studied population. The patients were predominantly male (31/32) with smoking background (32/32) and alcohol abuse (31/32). Eight patients (25%) have suffered from tumor recurrence and 3/32 (9.4%) metastasis. A single patient suffered from tumor recurrence followed by metastasis at distance. Two patients have died from reasons not related to cancer, and eight died from cancer. The tumor recurrence and the metastasis were determining characteristics of the impact on the patient's survival - Figure 1 . The cut threshold (3.32-FC vs p-value 10−7) was applied for the gene selection with reduced regulation (green dots / right side) or super expressed (red dots / left side) in LSCC samples. (b) Bidirectional unsupervised hierarchy grouping is illustrated in a heat map diagram. Each column represents a sample and each row indicates a gene. Cluster tree sample is shown at the top, while for the genes it appears at left. In all samples, the relative levels of genic expression are shown in color scales (red, super expressed; green, lower than average; black expression, median). Eight members of the HOX family are highlighted in red on the right side.
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Validation of the super expression of the members of the HOX gene in LSCC. Analysis of the genic expression by RT-qPCR confirmed that all 8 members of the HOX gene family were super expressed in the tumors in comparison with the margins - Figure 2 and Table 2 . In general, the changes of the detected expressions by RT-qPCR were even more evident than the ones observed at the microarrays analysis. The level of relative expression (double change) of the gene HOXC four members between LSCC and margins varied from 6.4 to 44.6 times (Figure 2a-d) . For the members of the HOXD group, the Fourteen HOX genes were identified as super expressed in SCC tissues of head and neck, from which six corresponded to super expressed in our study - Figure 3 . We suggest that the HOX genes could be super expressed like a 
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Hox genes and laryngeal carcinogenesis cluster in tissues of head and neck by amplification events. The occurrence of genomic amplification in seven genic loci of the HOX gene was evaluated using the various data of the number of TCGA copies (CNV) 14 . We observed that the expression of most of the HOX genes that we found regulated in LSCC did not correlate with the number of copies alteration, except for HOXA10 that demonstrated some weak correlation (R = 0.2).
Besides, we used the TCGA database for the status analysis of the methylation of these seven genes 15 . Thus, we found that the expression levels of the methylation status were inversely correlated (correlation lower or equal to −0.5) for HOXA10, HOXC10, and HOXD11 ( Table 2) , indicating that the DNA methylation could be involved in the regulation of these HOX genes in SCC of head and neck.
HOXC8, HOXD10, and HOXD11 modulate the survival of the cell, proliferation and migration. For the functional analysis, the FADU and UMSCC14 lines were used, once they are lines of head and neck that express the HOX genes. The efficiency of the genic silencing was evaluated 48 hours after the transfection with siRNAs for HOXC8, HOXD10, and HOXD11 for RT-qPCR. The apoptosis and cellular feasibility were quantified by flow cytometry - Figure 3B , C. HOXC8 genic silencing altered the cellular feasibility and increased significantly the apoptosis in FADU cells, but had no effect over the cellular feasibility rates or apoptosis of UMSCC14 cells - Figure 3B 
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Discussion
In this study, we used the mRNA microarray analysis to investigate the genic expression signatures associated with carcinoma progression of larynx squamous cells. The analysis of 32 larynx tumors and 13 normal adjacent tissues identified 70 genes differentially expressed. A set of 30 genes was super expressed, from which we highlighted a group of eight members of the gene family HOX (HOXA10, HOXA11-S1, HOXC8, HOXC9, HOXC10, HOXC13,  HOXD10, and HOXD11) . This was the first observation of this relatively large number of HOX genes simultaneously super expressed in a type of tumor. RT-qPCR validation confirmed an impressive positive regulation of all the 8 HOX genes in tumor samples in comparison to normal tissue, 40 times in the case of HOXC13 gene (Figure 2) . Numerous examples of aberrant individual genic expression of HOX have been reported in cancer cases.
Additionally, to investigate the biological role of HOXC8, HOXD10 and HOXD11 genes in FADU and UMSCC14 cells, we performed a transwell migration test after 48 hours, transfected with the respective siRNAs. After 24 hours of cellular migration, we observed that the expression of any of the three HOX genes drastically decreased the cellular migration in FADU and UMSCC14 cells - Figure 5a , b. and UMSCC-14 (right). ANOVA followed by Bonferroni post hoc test was used for analytical analysis. Each experiment was performed three times and each one in triplicate.
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The mechanisms of deregulation are multiple and can be dependent on the tissues 16 . CpG methylation in the region promoting the genes acts as a significant epigenetic mechanism of genic silencing in tumors, while the demethylation can super express oncogenes.
The analysis of methylation status of the 7 HOX genes super expressed in LSCC, using TCGA database, showed an inverse correlation between the expression levels and the methylation status of HOXA10, HOXC10, and HOXD11, indicating that this could be the mechanism responsible for the regulation of these 3 HOX genes in head and neck cancer.
Aberrant methylation standards of DNA in a group of genes, including some HOX genes, were also found in breast cancer, ovarian cancer and melanoma [17] [18] [19] suggesting that this could be the main mechanism of HOX gene regulation in tumors, possibly enabling the tumorigenesis.
HOX gene expression is variable in different types of tumors. Although some HOX genes have been described as super expressed in a particular type of tumor, other reports showed its low regulation in a different type of tumor 20 . This variation of the expression profile among the different tumors indicates that the HOX genes can perform an oncogenic effect or tumor-suppressing function depending on the type of tumor. HOXD10, for example, turned up negative in gastric cancer and was considered as a candidate to tumor suppressor. HOXD10 restatement in the cell lines of gastric cancer resulted in significant inhibition of the cell survival, apoptosis induction and migration, and cell invasion reduction 21 . Evidence of altered expression of HOXD10 was also described in breast cancer, endometrium cancer and hepatocellular carcinoma [22] [23] [24] [25] in which the expression HOXD10 is reduced in epithelial cells, as the malignity increases, or is completely drained in the tumors in comparison to normal tissue. In the present study, despite not having a correlation between HOXD10 expression and the global survival rate, there was a meaningful positive regulation in LSCC samples in comparison with normal tissues. This is according to other studies that revealed expression levels significantly high in HOXD10 of head and neck cancer, mainly in squamous cell cancer of the oral cavity 26, 27 . Sharpe et al. 26 , for example, described HOXD10 as super expressed in head and neck tissues (oral cavity, oropharynges, pharynges) and line cells (tongue and pharynx). HOXD10 silencing resulted in proliferation involvement and cell invasion. New results also confirm the importance of HOXD10 for cell proliferation and migration.
HOXD11 was found with reduced regulation through a methylation pattern of a group of genes in breast cancer, ovarium cancer 17, 18 and melanoma 19 .
Here we found HOXD11 positively regulated in LSCC samples, agreeing with Sharp et al. and Rodini et al. data that described HOXD11 super expressed in head SCC 26, 27 , suggesting an important role for this gene at the development of this disease. Besides, our data suggests that HOXD11 gene contributes to the proliferation of tumor cells and cell migration.
HOXC8 gene also represents a variable pattern of expression. Adwan et al. 28 found immunolabelling for HOXC8 stronger in the margin tissue than in the tissue of the pancreatic ductal adenocarcinoma and was described as inversely related to the progression and metastasis of this type of cancer 28 . All the 10/13
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Hox genes and laryngeal carcinogenesis same, HOXC8 was reported as being super expressed in esophageal cancer and suggested as a potential prognostic marker for this kind of cancer 29 . Similarly, we identified high levels of expression in HOXC8 associated with a lower tumor differentiation. Other HOX genes here identified were also described deregulated in different types of tumor. Although the expression levels of the majority have not influenced the global survival rates, Hox family members identified as super expressed in LSCC in this study, except for HOXA10, contributed to distinguish the margin tumor tissue. HOX genes codify transition factors and are known for the acting at embryogenesis and regulation of biological processes such as cell differentiation, cell proliferation, and apoptosis, which are important mechanisms for the development of tissues and organs 16 . According to our results, it is possible to infer that the genetic program regulated by these eight HOX genes would be reactivated in LSCC and could be associated with tumor development. Our discoveries suggest that HOXC8, HOXD10, and HOXD11 are associated with the increase of proliferation and migration of tumor cells, while HOXC8 would also be involved in the regulation of cell survival. This is according to other studies that reported a decrease in the cell proliferation, migration or invasion after depletion of HOXC8 30 , HOXD10 and HOXD11 26 in breast cancer and carcinoma of squamous cells of head and neck, respectively.
Conclusion
We identified genes differentially expressed through the tracking in all the genome in LSCC samples. The results here presented revealed that 8 members of the HOX gene family (HOXA10, HOXA11-S1, HOXC8, HOXC9, HOXC10, HOXC13, HOXD10, and HOXD11) were significantly super expressed in LSCC samples in comparison to normal tissue. Our data indicate that these genes can have a significant role in the pathogenesis of LSCC tumors. The functional investigation with 3 of them (HOXC8, HOXD10, and HOXD11) showed involvement in biological processes related to the development of tumors with the ability to form colonies and cell migration. The results here presented support the hypothesis that the aberrant expression of HOX genes is associated with the development of LSCC and also justifies the additional investigation over the activity of the HOX gene family in LSCC and its potential role as a therapeutic target.
